Visby Medical raises approximately $55 million in a funding round led by Catalio Capital Management to enhance launch of its at-home STI test.
Visby Medical raises approximately $55 million in a funding round led by Catalio Capital Management to enhance launch of its at-home STI test.
06/17/25, 1:21 PM
Location
san joseMoney raised
$55 million
Industry
healthcare
Investors
John Doerr, Pitango Ventures, Blue Water Life Science Advisors, Cedars Sinai Medical Center, Nd Capital, Catalio Capital Management
Visby Medical has raised approximately $55 million, potentially reaching $65 million, in its latest financing round led by Catalio Capital Management. Existing investors also participated, including ND Capital and Cedars Sinai Medical Center. The funding will accelerate the launch of their FDA-authorized at-home Women's Sexual Health Test. New board members will enhance the company's operational capabilities.
Company Info
Location
3010 n. 1st street
san jose, california, united states
Additional Info
Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The Company developed a proprietary technology platform that is the world’s first instrument-free, single-use PCR platform that fits in the palm of your hand and rapidly tests for serious respiratory and sexually transmitted infections.